Articles Tagged With:
-
The Incidence of Dementia May Be Declining
In community-dwelling people from Bronx County, New York, there was a sharp decrease in dementia incidence in those born after mid-1929, which could not be readily explained by changes in the prevalence of cardiovascular diseases, higher education, or increased racial/ethnic diversity.
-
How Helpful Is Bevacizumab in Recurrent Glioblastoma?
In a randomized Phase III trial, the addition of bevacizumab to lomustine did not improve overall survival in patients with recurrent glioblastoma compared to lomustine alone.
-
Ethics if Patient Wants to Transfer Embryos With Genetic Anomalies
Pre-implantation testing of embryos can detect genetic anomalies linked to serious health-affecting disorders. While patients rarely request that such embryos be transferred, it does happen.
-
Report Examines How Research on Donated Organs Can Be Ethically Performed
Research on how to improve the quality and quantity of organs available for transplant poses multiple ethical challenges.
-
ED Patients’ Documented DNR Status Might Conflict With Family’s Demands
Even if an ED patient’s do not resuscitate status is well-documented, family members may demand resuscitation — sometimes vehemently.
-
Study: Timing of Advance Directive Linked to Aggressive End-of-Life Care
Did a patient complete an advance directive in his or her last months of life? If so, there is a greater chance of choosing aggressive care, found a recent study.
-
Study: Residents Want to Be Involved in Error Disclosure
Residents’ error disclosure skills have improved over time, largely due to informal learning experiences, found a recent study.
-
Ethical Controversy Persists in Medical Aid in Dying Laws
Recently passed state laws allowing physician-assisted death are in conflict with a newly updated position statement from the American College of Physicians objecting to the practice.
-
Infectious Disease Alert Updates
The Origins of Smallpox Vaccine Virus; No More Fun Helping Mommy Bake; Annual Influenza Vaccination of Physicians
-
Zoster Vaccine Recombinant Adjuvanted (Shingrix)
The FDA has approved a second zoster vaccine for the prevention of shingles in adults.